Seroquel XR (Quetiapine Fumarate) Patent Expiration, LOE Window & CMS Spending

Seroquel XR (Quetiapine Fumarate) by Cheplapharm Arzneimittel Gmbh: Off-Patent Genericized (AB Competition), 12 AB generics, $10.2M 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorCheplapharm Arzneimittel Gmbh
FDA Application & PathwayN022047 (NDA)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors12
2024 CMS Total Public Spend$10.2M
2024 Medicare Part D Spend$7.5M
2024 Medicaid Spend$2.7M
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel